PHAR Pharming Group N.V.

NASDAQ
$10.46

Pharming Group N.V. (PHAR) SEC Filings

Everything PHAR has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

3 filings
Date Form Filing
6-K Other Reg Fd
6-K Other
6-K Other Reg Fd

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.